The Immunomodulatory Properties of Vaccines in Early Life and Their Impact on Future Health: Untapped Potential and New Challenges

  • 12k

    Total downloads

  • 76k

    Total views and downloads

About this Research Topic

Submission closed

Background

Human newborns are highly susceptible to infection due to functionally distinct innate and adaptive immune responses. Successful immune defense relies on a fine balance between an effective inflammatory response to infection (disease resistance) and adequate anti-inflammatory mechanisms to prevent uncontrolled inflammation (disease tolerance).

The passive transfer of maternal immunity is considered central to anti-microbial defenses in early life. The proposed mechanisms center around active transport of maternal IgG through the placenta, providing systemic immunity during the first months after birth until the infant actively acquires immunity through exposure to pathogens or vaccines. Maternal immunization has the potential to substantially reduce morbidity and mortality from infectious diseases after birth. However, many gaps in knowledge regarding the immunobiology of maternal immunization prevent the optimal design and application of this successful public health intervention. Examples of those gaps are the clinical relevance of vaccine interference by maternal antibodies in terms of the active immunity induced in the infant by natural infection or immunization, the impact of vaccine antigen and timing of vaccination in pregnancy on passive antibody transfer, etc.

Effective early life immunization is another area of intense research but remains a moving target due to dynamic changes of the immune system over the first year of life. Emerging literature suggests that vaccines can have immunomodulatory effects beyond initiating antigen-specific adaptive responses. Epidemiologic studies have linked live attenuated vaccines given during the neonatal or infantile period (particularly BCG, the Bacille Calmette-Guerin vaccine against tuberculosis) to an unanticipated reduction in all-cause mortality, which greatly exceeds a reduction in mortality attributable to vaccine-specific disease prevention. Observational studies and randomized-controlled trials in Guinea-Bissau have shown near halving of neonatal mortality in low-birth weight children vaccinated with BCG at birth. The reduction in neonatal mortality was mainly due to fewer cases of neonatal sepsis, respiratory infections and fever. These observations suggest BCG and other live vaccines induce “heterologous” protection against antigenically diverse, unrelated pathogens. Similar to vaccines, early life infections can have effects on the unique neonatal immune system. One such observation is the association of bloodstream infections in critically ill preterm newborns with enhanced pathogen-specific mononuclear cell pathogen recognition receptors (PRR) expression in the setting of subsequent Gram-positive or Gram-negative bacteremia, which suggests that the neonatal innate immune system can remember previous activation such that responses to subsequent microbial challenges are altered. Similarly, histologic chorioamnionitis affecting preterm infants is associated with a significantly reduced risk of late onset sepsis, both with coagulase-negative Staphylococcus (most common) and other bacteria, implying that perinatal inflammation may enhance functional maturation of the preterm immune system.

One of the suggested mechanisms for heterologous protection against infection is innate immune memory, also known as “trained immunity”. It is posited that human innate immune memory may be mediated by changes in the number and function of innate immune cells with low turnover, such as NK cells and macrophages, but the molecular mechanisms are now starting to be unraveled. Newer data suggest that epigenetic and metabolic reprogramming of hematopoietic progenitors may account for long-term maintenance of trained immunity and its benefits. Immunization strategies leveraging vaccine-induced innate immune memory in a controlled way could be used to prime the immune system in order to improve immunogenicity to subsequent homologous or heterologous boosters in later infancy. In addition to reducing overall risk of infection in vulnerable populations, vaccine-induced heterologous immunomodulatory effects can impact multiple facets of future health, such as propensity to allergic and autoimmune diseases.

List of subjects, which will be addressed:
- The immunobiology of maternal immunization and effects on fetal/infant immunity
- Strategies to boost immunization during pregnancy
- Vaccines to prevent congenital infections: how close are we?
- Harnessing trained immunity in national immunization programs
- Details matter: putting data into action to optimize global immunization practices
- Precision vaccinology in the era of OMICS
- Sex differences in vaccine responses
- Vaccine interactions with the Microbiome: do they define health and disease?
- The BCG experience: safety, immunogenicity, heterologous effects
- Vaccines to prevent neonatal sepsis

Keywords: Neonates, Infants, Infections, Vaccines, Innate Immunity, Adaptive Immunity

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

    In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.